AskBio CEO Sheila Mikhail wages two-front battle against diseases – her own, other genetic threats
Seventeen months after negotiating a whopping $4 billion buyout deal with German pharma giant Bayer, Asklepios BioPharmaceutical (AskBio) CEO and co-founder Sheila Mikhail says the pioneering gene therapy company is hitting all its targets. And she continues to wage her own battle with lupus.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed